Literature DB >> 21521934

Relative associations of polycystic ovarian syndrome vs metabolic syndrome with thyroid function, volume, nodularity and autoimmunity.

I Anaforoglu1, M Topbas, E Algun.   

Abstract

BACKGROUND: The relative associations of polycystic ovarian syndrome (PCOS) and metabolic syndrome (MS) with the risk for thyroid disease (thyroid function, volume, nodularity and autoimmunity) are unknown.We compared thyroid features and function in patients with PCOS and control subjects by the presence of MS.
METHODS: We recruited 84 women with PCOS and 81 age-matched healthy controls. PCOS was defined according to the Rotterdam criteria. Thyroid ultrasound and function tests were performed in all.
RESULTS: Although thyroid disease was more prevalent in women with PCOS, ovarian disease was not significantly associated with the risk for thyroid disease. Thyroid volume did not differ between women with PCOS and control subjects (13.7±8.6 vs 12.4±4.4 ml, respectively; p=0.2); however, it differed significantly between subjects with and without MS (regardless of PCOS status): 19.1±14.8 vs 12.4±4.9 ml, respectively; p=0.001). Antithyroglobulin and antithyroid peroxidase antibody levels also were significantly higher in subjects with MS, but not in participants with PCOS vs control subjects. Overall, TSH level correlated significantly with body mass index (BMI), weight, waist circumference, diastolic blood pressure, and levels of LDL cholesterol, triglycerides, and HDL cholesterol. Thyroid volume correlated significantly with age, weight, BMI, waist circumference, systolic blood pressure, 120-min postprandial glucose and HDL level.
CONCLUSIONS: PCOS alone was not associated with thyroid disease in our population. However, MS and some of its components appear to be related to thyroid volume, function, and antithyroid antibody levels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521934     DOI: 10.3275/7681

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

1.  High prevalence of thyroid dysfunction and autoimmune thyroiditis in adolescents after elimination of iodine deficiency in the Eastern Black Sea Region of Turkey.

Authors:  Mehmet Bastemir; Rifat Emral; Gurbuz Erdogan; Sevim Gullu
Journal:  Thyroid       Date:  2006-12       Impact factor: 6.568

Review 2.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

3.  Insulin-like growth factor-I: autocrine secretion by human thyroid follicular cells in primary culture.

Authors:  B Tode; M Serio; C M Rotella; G Galli; F Franceschelli; A Tanini; R Toccafondi
Journal:  J Clin Endocrinol Metab       Date:  1989-09       Impact factor: 5.958

4.  Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.

Authors:  Annemieke Roos; Stephan J L Bakker; Thera P Links; Rijk O B Gans; Bruce H R Wolffenbuttel
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

5.  Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases.

Authors:  C J van Gelderen; M L Gomes dos Santos
Journal:  J Reprod Med       Date:  1993-05       Impact factor: 0.142

Review 6.  Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function.

Authors:  Yaron Tomer; Terry F Davies
Journal:  Endocr Rev       Date:  2003-10       Impact factor: 19.871

7.  Thyroid function in humans with morbid obesity.

Authors:  Marina A Michalaki; Apostolos G Vagenakis; Aggeliki S Leonardou; Marianna N Argentou; Ioannis G Habeos; Maria G Makri; Agathoklis I Psyrogiannis; Fotis E Kalfarentzos; Venetsana E Kyriazopoulou
Journal:  Thyroid       Date:  2006-01       Impact factor: 6.568

8.  Obesity is associated with increased serum TSH level, independent of thyroid function.

Authors:  Mehmet Bastemir; Fulya Akin; Esma Alkis; Bunyamin Kaptanoglu
Journal:  Swiss Med Wkly       Date:  2007-07-28       Impact factor: 2.193

9.  Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome.

Authors:  Giovanni De Pergola; Francesco Giorgino; Ritanna Benigno; Pietro Guida; Riccardo Giorgino
Journal:  Obesity (Silver Spring)       Date:  2008-08-14       Impact factor: 5.002

10.  Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women.

Authors:  Hyun Tae Park; Geum Joon Cho; Ki Hoon Ahn; Jung Ho Shin; Soon Cheol Hong; Tak Kim; Jun Young Hur; Young Tae Kim; Kyu Wan Lee; Sun Haeng Kim
Journal:  Maturitas       Date:  2009-02-27       Impact factor: 4.342

View more
  7 in total

1.  Antithyroid Peroxidase Antibodies in Women with Polycystic Ovary Syndrome.

Authors:  Maya Menon; Vijayalakshmi Ramachandran
Journal:  J Obstet Gynaecol India       Date:  2016-06-08

2.  Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome.

Authors:  Cevdet Duran; Mustafa Basaran; Orkide Kutlu; Zehra Kucukaydin; Suleyman Bakdik; Ferda Sevimli Burnik; Uysaler Aslan; Sami Said Erdem; Samil Ecirli
Journal:  Endocrine       Date:  2014-12-19       Impact factor: 3.633

3.  Is there a Relationship between Serum IGF-1 and Thyroid Nodule, Thyroid or Ovarian Volume in Polycystic Ovarian Syndrome?

Authors:  O Topaloglu; B Evren; M Uzun; S Yologlu; E Guldogan; I Sahin
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

4.  The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis.

Authors:  Danfeng Du; Xuelian Li
Journal:  Int J Clin Exp Med       Date:  2013-10-25

5.  Efficacy of Metformin for Benign Thyroid Nodules in Subjects With Insulin Resistance: A Systematic Review and Meta-Analysis.

Authors:  Miao Sui; Yuan Yu; Huifeng Zhang; Hongjie Di; Chao Liu; Yaofu Fan
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-28       Impact factor: 5.555

Review 6.  Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto's Thyroiditis: How Far Is Our Understanding?

Authors:  Natalia Zeber-Lubecka; Ewa E Hennig
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

7.  Ovarian Reserve and Serum Concentration of Thyroid Peroxidase Antibodies in Euthyroid Women With Different Polycystic Ovary Syndrome Phenotypes.

Authors:  Agnieszka Adamska; Agnieszka Łebkowska; Anna Krentowska; Justyna Hryniewicka; Marcin Adamski; Monika Leśniewska; Aleksandra Maria Polak; Irina Kowalska
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-28       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.